- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Therapeutic Potential of Nanobodies ; volume:34 ; number:1 ; day:4 ; month:11 ; year:2019 ; pages:11-26 ; date:2.2020
BioDrugs ; 34, Heft 1 (4.11.2019), 11-26, 2.2020
- Creator
-
Jovčevska, Ivana
Muyldermans, Serge
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-019-00392-z
- URN
-
urn:nbn:de:101:1-2020042622490583135990
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jovčevska, Ivana
- Muyldermans, Serge
- SpringerLink (Online service)
Other Objects (12)
Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies
Nanobodies as potential tools for microbiological testing of live biotherapeutic products
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Nanobodies – effektive Immunwaffen gegen Krebs
Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7
ASC nanobodies to counteract the consequences of inflammasome activation
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
The therapeutic potential of purified cannabidiol
Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies
A two-step approach for the design and generation of nanobodies
Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies
Nanobodies as potential tools for microbiological testing of live biotherapeutic products
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Nanobodies – effektive Immunwaffen gegen Krebs
Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7
ASC nanobodies to counteract the consequences of inflammasome activation
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
The therapeutic potential of purified cannabidiol
Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies
A two-step approach for the design and generation of nanobodies
Antagonistic nanobodies implicate mechanism of GSDMD pore formation and potential therapeutic application
Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies
Nanobodies as potential tools for microbiological testing of live biotherapeutic products
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Nanobodies – effektive Immunwaffen gegen Krebs
Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7
ASC nanobodies to counteract the consequences of inflammasome activation
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
The therapeutic potential of purified cannabidiol
Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies